ArriVent BioPharma (AVBP) News Today → Elon’s New A.I. Device is About to Shock the World (From InvestorPlace) (Ad) Free AVBP Stock Alerts $16.61 +1.17 (+7.58%) (As of 03:35 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineArriVent BioPharma (NASDAQ:AVBP) Stock Price Up 6%americanbankingnews.com - April 28 at 3:16 AMArriVent BioPharma (NASDAQ:AVBP) Trading Up 6%marketbeat.com - April 26 at 5:57 PMArriVent BioPharma (NASDAQ:AVBP) Sets New 1-Year Low at $14.35marketbeat.com - April 25 at 7:46 PMArriVent Appoints Kristine Peterson to its Board of Directorsglobenewswire.com - April 22 at 4:05 PMArriVent BioPharma (NASDAQ:AVBP) Shares Up 4.9%americanbankingnews.com - April 21 at 2:32 AMArriVent BioPharma (NASDAQ:AVBP) Sets New 1-Year Low at $15.38marketbeat.com - April 18 at 1:56 PMArriVent BioPharma (NASDAQ:AVBP) Shares Down 3.3% marketbeat.com - April 17 at 12:20 PMArriVent BioPharma (NASDAQ:AVBP) Sets New 52-Week Low at $16.83marketbeat.com - April 12 at 3:59 PMArriVent BioPharma (NASDAQ:AVBP) Stock Price Up 3.1%marketbeat.com - April 11 at 1:48 PMArriVent BioPharma (NASDAQ:AVBP) Trading Down 2.4%marketbeat.com - April 8 at 11:59 AMLifesci Capital Comments on ArriVent BioPharma, Inc.'s FY2024 Earnings (NASDAQ:AVBP)marketbeat.com - April 3 at 6:15 AMBuy Rating on ArriVent BioPharma Highlighting Furmonertinib’s Potential in NSCLC Treatment Landscapemarkets.businessinsider.com - April 1 at 6:32 PMArriVent BioPharma (NASDAQ:AVBP) Sees Strong Trading Volumemarketbeat.com - April 1 at 2:01 PMArriVent BioPharma, Inc.: ArriVent BioPharma Reports Full Year 2023 Financial Resultsfinanznachrichten.de - March 29 at 7:49 AMInnoCare Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinibbusinesswire.com - March 28 at 8:30 PMArriVent BioPharma reports FY resultsmsn.com - March 28 at 8:02 PMArriVent BioPharma Reports Full Year 2023 Financial Resultsglobenewswire.com - March 28 at 4:05 PMArriVent BioPharma (NASDAQ:AVBP) Stock Price Up 5.2%marketbeat.com - March 26 at 4:46 PMArriVent BioPharma (NASDAQ:AVBP) Shares Down 2.8% marketbeat.com - March 25 at 3:20 PMArriVent BioPharma (NASDAQ:AVBP) Sets New 12-Month Low at $17.63marketbeat.com - March 21 at 6:43 PMArriVent BioPharma (NASDAQ:AVBP) Shares Gap Down to $18.13marketbeat.com - March 20 at 12:45 PMArriVent BioPharma (NASDAQ:AVBP) Trading Down 5.6%marketbeat.com - March 18 at 12:44 PMArriVent BioPharma (NASDAQ:AVBP) Hits New 12-Month Low at $18.06marketbeat.com - March 14 at 3:16 PMArrivent Biopharma Inc (AVBP)uk.investing.com - March 6 at 5:02 PMArriVent BioPharma (NASDAQ:AVBP) Shares Gap Down to $22.75marketbeat.com - March 5 at 1:23 PMBuy Rating on ArriVent BioPharma: Advancing NSCLC Treatment with Promising Furmonertinib Prospectsmarkets.businessinsider.com - March 5 at 1:29 AMArriVent BioPharma, Inc.'s (NASDAQ:AVBP) Quiet Period Will End on March 6thmarketbeat.com - February 28 at 1:18 AMJefferies Financial Group Initiates Coverage on ArriVent BioPharma (NASDAQ:AVBP)marketbeat.com - February 20 at 7:32 AMArriVent BioPharma (NASDAQ:AVBP) Stock Price Down 3.6%marketbeat.com - February 9 at 3:02 PM Get ArriVent BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AVBP and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon’s New A.I. Device is About to Shock the World (Ad)Using this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. AVBP Media Mentions By Week AVBP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AVBP News Sentiment▼-0.080.34▲Average Medical News Sentiment AVBP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AVBP Articles This Week▼42▲AVBP Articles Average Week Get ArriVent BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AVBP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Verve Therapeutics News Today CureVac News Today ORIC Pharmaceuticals News Today Phathom Pharmaceuticals News Today AnaptysBio News Today Phibro Animal Health News Today Astria Therapeutics News Today Altimmune News Today Adlai Nortye News Today Stoke Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AVBP) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsAI finds its first serious applicationWall Street StarThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press4 coins to be the “Next Bitcoin”True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ArriVent BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
